Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic. Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC. John Yianitsas, Vice President of New Business Development at Presco, said PVC…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic.

Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC.

John Yianitsas, Vice President of New Business Development at Presco, said PVC is a great fit when making PPE because it creates a tough-to-penetrate barrier, is easily cleanable, and can be either heat sealed or sewed. That gives users not only the opportunity to use PVC items more than once but also to utilize the material in a number of different ways.

“PVC can be used not only just for gowns, but drapes, barriers, and things like that, which is why I think it’s such a great product that can be used over and over again. It’s not a one-and-done,” Yianitsas said.

Few could say they saw a pandemic coming, so there was a rush to get PPE to those who needed it at the beginning of the pandemic. Luckily for those relying on Presco, the Texas-based company was able to turn around its products quickly since it was relying only on domestic materials and not waiting for supplies to arrive from abroad.

“I think the key factor in all this is the fact that we’re a domestic supplier. We source all our raw materials domestically, so we didn’t have to wait for anything to come in,” Yianitsas said. “Our ability to take an order and turn it around and fulfill it very, very quickly, the fact that we’re here in Sherman, Texas, gave us that opportunity to be able to respond very, very, quickly. Had we not had that capability, we would’ve been in the same boat as other people.”

Instead, Presco was able to help frontline workers in the United States do their job in a safe way, aiding the response when the country needed it most.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512